new molecules and indications for glp 1 medicines GLP-1 Market Trends Global Forecasts Report 2025: A $157.5 Bn Market by 2035 Five Unexpected New Uses for

This question concerns many patients prescribed Ozempic, Wegovy, or Rybelsus for type 2 diabetes or weight management

Common adverse effects include gastrointestinal symptoms such as nausea, vomiting, diarrhea, and constipation, which typically diminish over time with continued use and gradual dose escalation

Its dosing regimen starts gradually, increasing over time to the full 2.4 mg maintenance dose

Originally developed to regulate blood glucose level in patients with type 2 diabetes, these therapies have now gained significant attention for their role in weight management and broader metabolic health

Even though these otoprotective agents represent a promising new therapeutic strategy for ameliorating, delaying, or even preventing the impact of noise on hearing, finding the ideal therapeutic agent will remain a challenging topic for the future